Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tesaro names chief commercial officer

This article was originally published in Scrip

Executive Summary

Waltham, Massachusetts-based Tesaro, an oncology-focused biopharmaceutical company, has appointed Grant C Bogle to the newly created position of senior vice-president and chief commercial officer. In this role, Mr Bogle will report to Lonnie Moulder, CEO of Tesaro, and will lead the company's marketing, sales, and market access teams. Most recently he was senior vice-president, pharmaceutical and biotech solutions at McKesson Specialty Health, where he led the informatics, health economics and outcomes research, reimbursement access and safety services, and US Oncology Clinical Research business units.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC029273

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel